Download presentation
Presentation is loading. Please wait.
Published by자경 순 Modified over 6 years ago
1
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee J.J. Cherian, J. Parvizi, D. Bramlet, K.H. Lee, D.W. Romness, M.A. Mont Osteoarthritis and Cartilage Volume 23, Issue 12, Pages (December 2015) DOI: /j.joca Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
2
Fig. 1 Enrollment flowchart.
Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
3
Fig. 2 Mean IKDC subjective knee evaluation scores over time by treatment group. Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
4
Fig. 3 Mean VAS pain scores over time by treatment group.
Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.